Roadmaps to Regulation: New Psychoactive Substances
On 26 May 2016, the New Psychoactive Substances Act passed into UK law, rendering it illegal to buy, sell or supply any substance deemed to have psychoactive properties.
But what will happen to the public appetite for “legal highs,” and what will happen to the drugs themselves?
To mark the day, Amanda Feilding and the Beckley Foundation have released this chapter on NPS from our forthcoming report, “Roadmaps to Regulation: Cannabis, Psychedelics, MDMA and NPS.” The chapter explains the medical and social fallacies of applying a blanket ban to this vast array of chemically dissimilar substances, and strategises how we could legally regulate the unquellable market for NPS.
NPS in the Press: Amanda has shared her perspective on the myriad harms that this new legislation will bring with it in the Metro , Vice: Motherboard and the Mirror.
Roadmaps to Regulation: Cannabis, Psychedelics, MDMA, and NPS
Amanda Feilding (Coordinating Editor) and Nicola Singleton, with additional input from Alex Stevens, 2016
Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'
Addiction, 2012
Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans
PloS one, 2010
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series
Cephalalgia:an international journal of headache, 2010
Podcast
- All
Links
- All
Support
- All
BIPRP
- All
Science Talk
- All
Amanda's Talks
- All
- Video Talk
- Featured
- 2016 Onwards
- 2011-2015
- 2010 and Earlier
- Science Talk
- Policy Talk
One-pager
- All
Music
- All
Amanda Feilding
- All
Events
- All
Highlights
- All
Psilocybin for Depression
- All
Current
- All
Category
- All
- Science
- Policy
- Culture
Substance/Method
- All
- Opiates
- Novel Psychoactive Substances
- Meditation
- Trepanation
- LSD
- Psilocybin
- Cannabis/cannabinoids
- Ayahuasca/DMT
- Coca/Cocaine
- MDMA
Collaboration
- All
- Beckley/Brazil Research Programme
- Beckley/Maastricht Research Programme
- Exeter University
- ICEERS
- Beckley/Sant Pau Research Programme
- University College London
- New York University
- Cardiff University
- Madrid Computense University
- Ethnobotanicals Research Programme
- Freiburg University
- Medical Office for Psychiatry and Psychotherapy, Solothurn
- Beckley/Sechenov Institute Research programme
- Hannover Medical School
- Beckley/Imperial Research Programme
- King's College London
- Johns Hopkins University
Clinical Application
- All
- Depression
- Addictions
- Anxiety
- Psychosis
- PTSD
- Cancer
- Cluster Headaches
Policy Focus
- All
- Policy Reports
- Advisory Work
- Seminar Series
- Advocacy/Campaigns
Type of publication
- All
- Original research
- Report
- Review
- Opinion/Correspondence
- Book
- Book chapter
- Conference abstract
- Petition/campaign
Search type